A Safety and Efficacy Study of Hymecromone Tablets for the Treatment of Patients With COVID-19.

NCT05386420 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

304

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Hymecromone tablets
OTHER: Placebo

Sponsor

Shanghai Zhongshan Hospital